查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1883030

生物防御市场规模、占有率、成长及全球产业分析：按类型、应用和地区划分的洞察与预测（2024-2032 年）

Biodefense Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 请询问到货日

价格

生物防御市场成长驱动因素

随着世界各国面临日益严重的生物威胁、对生物恐怖主义的担忧日益加剧以及传染病疫情频繁，全球生物防御市场持续扩张。根据最新评估，生物防御市场预计将在 2024 年达到 153.9 亿美元，并在 2025 年增长至 162.3 亿美元。预计到 2032 年，该市场将飙升至 246.4 亿美元，预测期内复合年增长率 (CAGR) 为 6.1%。北美地区在先进的基础设施、强有力的政府计划和稳健的公私合作关係的推动下，于 2024 年以 42.88% 的市场占有率引领市场。

生物防御是一个涵盖生物威胁（无论是自然发生的、意外的还是人为造成的）的检测、预防和缓解的统称概念。从军事准备到民用保护，生物防御系统包括生物监测、诊断工具、疫苗、消毒技术和紧急应变能力。日益加剧的地缘政治紧张局势，例如俄乌衝突，进一步凸显了全球生物防御准备工作的迫切性。

市场驱动因素

市场成长的关键驱动因素是全球对生物风险日益增强的认识。流行病和反覆出现的传染病、合成生物学的进步以及高风险生物工程技术的发展，正迫使各国政府增加生物防御预算。製药和生物技术公司正在加速疫苗研发、诊断创新和治疗研究，以加强国家安全。

世界各国政府都在大力投资生物防御基础设施。值得注意的是，2025年4月，帕森斯公司从美国海军医学研究司令部获得了一份价值2400万美元的合同，用于开发传染病检测技术。人工智慧、机器学习、生物感测器和物联网系统的创新正在透过提高监测效率和实现即时威胁分析来变革生物防御。

市场限制因子

儘管发展势头强劲，但市场仍面临诸多挑战，例如研发成本高昂、审批流程漫长以及商业可行性的不确定性。许多生物防御产品针对的是罕见病原体，缺乏真实世界疫情数据，这使得企业难以进行大规模测试。

此外，由于缺乏政府采购计画的保障，研发投资的回收存在不确定性。责任问题、严格的监管流程和严格的生物安全法规也限制了市场准入，尤其是对于中小型生物技术公司而言。

市场机会

新冠肺炎、伊波拉和猴痘等传染病疫情的增加，凸显了快速反应疫苗、治疗方法和先进生物监测系统的必要性。这为技术开发人员创造了新的机遇，尤其是在基因组学、基于人工智慧的威胁预测和便携式检测系统等领域。

加强政府、生技公司和研究机构之间的合作，正在增强能力建设。预计未来十年，全球向数位化生物安全、预警系统和下一代生物感测器的转型将为产业参与者创造重大机会。

市场趋势

影响市场的关键趋势是先进监测和消毒技术的日益普及。 2024年，紫外线 (UV) 系统因其高效的微生物灭活效果和对快速消毒工具的强劲需求，在技术方面引领市场。生物感测器预计将成为成长最快的系统领域，能够在军事、边境管制和临床应用中实现精准、即时的威胁侦测。

合成生物学、快速诊断、基因组学和载体疫苗等领域的技术进步也在革新生物防御。 2022年2月，Tesseragen Biotechnology与Biomade合作，增强其人工智慧驱动的发酵生物製造平台。这显示生物技术和人工智慧在生物防御领域的融合日益加深。

细分市场概览

依技术划分：

紫外线技术将在2024年占主导地位，并由于消毒需求旺盛，将继续保持成长最快的技术地位。伽玛射线、冷等离子体和微波加热技术的应用也不断扩展，尤其是在灭菌和去污领域。

依系统划分：

受生物恐怖主义和传染病爆发日益增长的担忧推动，生物危害检测系统在2024年占了最大的市场占有率。由于生物感测器的快速小型化和现场可用性的提高，预计生物感测器将在2025年至2032年间实现最快成长。

最终用户：

军事组织将在2024年占最大的市场占有率，这反映了全球安全问题的日益关注。由于对疫苗和治疗药物的投资增加，製药和生物技术公司预计将成为成长最快的领域。

区域洞察

北美将在2024年继续保持最大的区域市场地位，达到66亿美元，这得益于“生物盾牌计划”（Project Bioshield）和“生物医学高级研究与发展局”（BARDA）等项目的支持。美国国立卫生研究院 (NIH)、疾病管制与预防中心 (CDC) 和国防部 (DoD) 的频繁投资（例如，SIGA Technologies 于 2024 年与国防部签订的 TPOXX 合约）持续巩固了其在该地区的市场领导地位。

欧洲预计将成为成长最快的地区，这得益于政府的大力资助、HERA 计划以及重大合同，例如 Smiths Detection 与国防部签订的价值 8960 万美元的化学威胁检测合同。

在亚太地区，疾病爆发的增加、军事现代化以及生物监测投资的扩大，正在创造丰厚的市场机会。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：主要发现

  • 主要行业趋势 - 主要合约和协议、併购和合作
  • 最新技术进展
  • 波特五力分析
  • 供应链分析
  • 定性分析 - COVID-19 疫情对全球生物防御市场的影响
  • 全球生物防御市场监理分析市场

第五章：全球生物防御市场分析、洞察与预测（2019-2032）

  • 主要发现/定义
  • 市场分析、洞察与预测 - 按技术分类
    • 微波加热
    • 紫外线
    • 伽玛射线辐照
    • 冷等离子体
    • 其他
  • 市场分析、洞察与预测 - 按系统分类
    • 数位生物监测网络
    • 早期预警系统
    • 生物危害检测系统
    • 人工智慧辅助监测系统
    • 生物感测器
    • 其他
  • 市场分析、洞察与预测 - 按最终用户分类
    • 军事
    • 国土安全部
    • 医院及诊所
    • 製药和生技公司
    • 病毒学实验室
  • 市场分析、洞察与预测 - 按地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 中东和非洲
    • 拉丁美洲

第六章：北美生物防御市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲生物防御市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 美国王国
    • 德国
    • 法国
    • 俄罗斯
    • 欧洲其他地区

第八章 亚太生物防御市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区

第九章 中东与非洲生物防御市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 伊朗
    • 以色列
    • 沙乌地阿拉伯
    • 土耳其
    • 中东和非洲其他地区

第十章拉丁美洲生物防御市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲国家

第11章：竞争分析

  • 全球市场排名分析（2024）
  • 竞争格局概览

第12章：公司简介

  • AirBoss Defense Group, Inc.（美国）
  • Bioquell，艺康集团旗下公司（美国）
  • Bio-Rad Laboratories, Inc.（美国）
  • BlueDot Inc.（加拿大）
  • E4life Srl （澳洲）
  • Emergent BioSolutions Inc.（美国）
  • SIGA Technologies, Inc.（美国）
  • Dynavax Technologies（美国）
  • Alnylam Pharmaceuticals, Inc.（美国）
  • Ichor Medical Systems Inc.（美国）
  • Bavarian Nordic A/S（丹麦）
  • SKAN AG（瑞士）
  • Smiths Detection Group Ltd（英国）
  • Parsons Corporation（美国）
Product Code: FBI113684

Growth Factors of biodefense Market

The global biodefense market continues to expand as nations worldwide confront escalating biological threats, rising bioterrorism concerns, and increasingly frequent infectious disease outbreaks. According to the latest assessment, the biodefense market size reached USD 15.39 billion in 2024, is projected to grow to USD 16.23 billion in 2025, and is expected to further surge to USD 24.64 billion by 2032, reflecting a CAGR of 6.1% during the forecast period. North America dominated the landscape in 2024 with a 42.88% market share, driven by advanced infrastructure, robust government programs, and strong private-public collaborations.

Biodefense encompasses the detection, prevention, and mitigation of biological threats-whether naturally occurring, accidental, or intentional. From military preparedness to civilian protection, biodefense systems involve biosurveillance, diagnostic tools, vaccines, decontamination technology, and emergency response capabilities. Increasing geopolitical tensions, such as those escalated by the Russia-Ukraine conflict, further emphasize the urgency for global biodefense preparedness.

Market Drivers

A key driver behind market growth is the heightened global awareness of biological risks. The recurrence of pandemics and infectious diseases, coupled with advances in synthetic biology and high-risk bioengineering capabilities, has prompted governments to expand biodefense budgets. Pharmaceutical and biotechnology companies are accelerating vaccine development, diagnostics innovation, and therapeutic research to strengthen national security readiness.

Governments worldwide are investing heavily in biodefense infrastructure. Notably, in April 2025, Parsons Corporation secured a USD 24 million U.S. Naval Medical Research Command contract to advance infectious disease detection technologies. Innovations in AI, machine learning, biosensors, and IoT systems are transforming biodefense by improving surveillance efficiency and enabling real-time threat analysis.

Market Restraints

Despite strong momentum, the market faces challenges including high R&D costs, long approval timelines, and uncertainty surrounding commercial viability. Because many biodefense products target rare pathogens with limited real-world outbreak data, companies encounter difficulties in conducting large-scale trials.

Moreover, without guaranteed government procurement programs, recovering development investments becomes uncertain. Liability concerns, highly regulated pathways, and stringent biosafety rules also limit participation-particularly among smaller biotech firms.

Market Opportunities

The rising prevalence of outbreaks such as COVID-19, Ebola, and mpox has underscored the need for rapid-response vaccines, therapeutics, and advanced biosurveillance systems. This is creating new opportunities for technology developers, particularly in genomics, AI-driven threat prediction, and portable detection systems.

Increasing collaboration between governments, biotech firms, and research institutions is strengthening capability-building efforts. The global shift toward digital biosecurity, early warning systems, and next-generation biosensors is expected to be a major opportunity for industry players over the next decade.

Market Trends

A significant trend shaping the market is the growing adoption of advanced surveillance and disinfection technologies. UV light systems led the market by technology in 2024 due to their effectiveness in microbial inactivation and strong demand for rapid sterilization tools. Biosensors are expected to be the fastest-growing system segment, enabling accurate, real-time threat detection across military, border control, and clinical applications.

Breakthroughs in synthetic biology, rapid diagnostics, genomics, and vector-based vaccines are also transforming biodefense preparedness. In February 2022, TeselaGen Biotechnology signed a collaboration with BioMADE to enhance AI-driven fermentation biomanufacturing platforms-highlighting the rising convergence of biotechnology and artificial intelligence in biodefense.

Segmentation Overview

Technology:

UV light dominated in 2024 and remains the fastest-growing technology due to high demand for disinfection. Gamma radiation, cold plasma, and microwave heating are also expanding applications, particularly in sterilization and decontamination.

System:

Biohazard detection systems accounted for the largest share in 2024, driven by rising bioterrorism and outbreak concerns. Biosensors will grow the fastest from 2025-2032 due to rapid miniaturization and field operability.

End User:

Military forces held the largest share in 2024, reflecting heightened global security concerns. Pharmaceutical & biotech companies are expected to be the fastest-growing segment due to increased investment in vaccines and therapeutics.

Regional Insights

North America remained the largest regional market in 2024, valued at USD 6.60 billion, supported by programs such as Project BioShield and BARDA. Frequent investments from NIH, CDC, and the DoD-such as SIGA Technologies' DOD contract for TPOXX in 2024-continue to strengthen the region's market leadership.

Europe is projected to be the fastest-growing region, driven by strong government funding, HERA initiatives, and major contracts such as Smiths Detection's USD 89.6 million MoD award for chemical threat detection.

Asia Pacific presents lucrative opportunities due to rising disease outbreaks, military modernization, and expanded biosurveillance investments.

Conclusion

Given rising biological threats, geopolitical instability, and rapid advances in biotechnology, the biodefense market is set to grow steadily from USD 15.39 billion in 2024 to USD 24.64 billion by 2032. Increasing global funding, technological innovation, and the demand for rapid detection and response systems will play central roles in shaping market evolution.

By Segmentation By Technology

  • UV Light
  • Gamma Radiation
  • Cold Plasma
  • Microwave Heating
  • Others

By System

  • Digital Biosurveillance Networks
  • Early Warning Systems
  • Biohazard Detection Systems
  • AI-Assisted Surveillance System
  • Biosensors
  • Others

By End User

  • Military Forces
  • Homeland Security
  • Hospitals & Clinics
  • Pharmaceutical & Biotech Companies
  • Virological Research Institutes

By Region

  • North America (By Technology, By System, By End User, By Country)
    • U.S. (By End User)
    • Canada (By End User)
  • Europe (By Technology, By System, By End User, By Country)
    • U.K. (By End User)
    • Germany (By End User)
    • France (By End User)
    • Russia (By End User)
    • Rest of Europe (By End User)
  • Asia Pacific (By Technology, By System, By End User, By Country)
    • China (By End User)
    • India (By End User)
    • Japan (By End User)
    • South Korea (By End User)
    • Rest of Asia Pacific (By End User)
  • Middle East & Africa (By Technology, By System, By End User, By Country)
  • Iran (By End User)
    • Israel (By End User)
    • Saudi Arabia (By End User)
    • Turkey (By End User)
    • Rest of Middle East & Africa (By End User)
  • Latin America (By Technology, By System, By End User, By Country)
    • Brazil (By End User)
    • Argentina (By End User)
    • Mexico (By End User)
    • Rest of Latin America (By End User)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Key Industry Developments - Key Contracts & Agreements, Mergers, Acquisitions and Partnerships
  • 4.2. Latest Technological Advancements
  • 4.3. Porters Five Forces Analysis
  • 4.4. Supply Chain Analysis
  • 4.5. Qualitative Insights - Impact of COVID-19 Pandemic on Global Biodefense Market
  • 4.6. Regulatory Analysis on Global Biodefense Market

5. Global Biodefense Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Key Findings / Definition
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Microwave Heating
    • 5.2.2. UV Light
    • 5.2.3. Gamma Radiation
    • 5.2.4. Cold Plasma
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By System
    • 5.3.1. Digital Biosurveillance Networks
    • 5.3.2. Early Warning Systems
    • 5.3.3. Biohazard Detection Systems
    • 5.3.4. AI-Assisted Surveillance System
    • 5.3.5. Biosensors
    • 5.3.6. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Military Forces
    • 5.4.2. Homeland Security
    • 5.4.3. Hospitals & Clinics
    • 5.4.4. Pharmaceutical & Biotech Companies
    • 5.4.5. Virological Research Institutes
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Middle East & Africa
    • 5.5.5. Latin America

6. North America Biodefense Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Technology
    • 6.1.1. Microwave Heating
    • 6.1.2. UV Light
    • 6.1.3. Gamma Radiation
    • 6.1.4. Cold Plasma
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By System
    • 6.2.1. Digital Biosurveillance Networks
    • 6.2.2. Early Warning Systems
    • 6.2.3. Biohazard Detection Systems
    • 6.2.4. AI-Assisted Surveillance System
    • 6.2.5. Biosensors
    • 6.2.6. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Military Forces
    • 6.3.2. Homeland Security
    • 6.3.3. Hospitals & Clinics
    • 6.3.4. Pharmaceutical & Biotech Companies
    • 6.3.5. Virological Research Institutes
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 6.4.1.1.1. Military Forces
        • 6.4.1.1.2. Homeland Security
        • 6.4.1.1.3. Hospitals & Clinics
        • 6.4.1.1.4. Pharmaceutical & Biotech Companies
        • 6.4.1.1.5. Virological Research Institutes
    • 6.4.2. Canada
      • 6.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 6.4.2.1.1. Military Forces
        • 6.4.2.1.2. Homeland Security
        • 6.4.2.1.3. Hospitals & Clinics
        • 6.4.2.1.4. Pharmaceutical & Biotech Companies
        • 6.4.2.1.5. Virological Research Institutes

7. Europe Biodefense Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Technology
    • 7.1.1. Microwave Heating
    • 7.1.2. UV Light
    • 7.1.3. Gamma Radiation
    • 7.1.4. Cold Plasma
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By System
    • 7.2.1. Digital Biosurveillance Networks
    • 7.2.2. Early Warning Systems
    • 7.2.3. Biohazard Detection Systems
    • 7.2.4. AI-Assisted Surveillance System
    • 7.2.5. Biosensors
    • 7.2.6. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Military Forces
    • 7.3.2. Homeland Security
    • 7.3.3. Hospitals & Clinics
    • 7.3.4. Pharmaceutical & Biotech Companies
    • 7.3.5. Virological Research Institutes
  • 7.4. Market Analysis, Insights and Forecast - By Country
    • 7.4.1. U.K.
      • 7.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.1.1.1. Military Forces
        • 7.4.1.1.2. Homeland Security
        • 7.4.1.1.3. Hospitals & Clinics
        • 7.4.1.1.4. Pharmaceutical & Biotech Companies
        • 7.4.1.1.5. Virological Research Institutes
    • 7.4.2. Germany
      • 7.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.2.1.1. Military Forces
        • 7.4.2.1.2. Homeland Security
        • 7.4.2.1.3. Hospitals & Clinics
        • 7.4.2.1.4. Pharmaceutical & Biotech Companies
        • 7.4.2.1.5. Virological Research Institutes
    • 7.4.3. France
      • 7.4.3.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.3.1.1. Military Forces
        • 7.4.3.1.2. Homeland Security
        • 7.4.3.1.3. Hospitals & Clinics
        • 7.4.3.1.4. Pharmaceutical & Biotech Companies
        • 7.4.3.1.5. Virological Research Institutes
    • 7.4.4. Russia
      • 7.4.4.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.4.1.1. Military Forces
        • 7.4.4.1.2. Homeland Security
        • 7.4.4.1.3. Hospitals & Clinics
        • 7.4.4.1.4. Pharmaceutical & Biotech Companies
        • 7.4.4.1.5. Virological Research Institutes
    • 7.4.5. Rest of Europe
      • 7.4.5.1. Market Analysis, Insights and Forecast - By End User
        • 7.4.5.1.1. Military Forces
        • 7.4.5.1.2. Homeland Security
        • 7.4.5.1.3. Hospitals & Clinics
        • 7.4.5.1.4. Pharmaceutical & Biotech Companies
        • 7.4.5.1.5. Virological Research Institutes

8. Asia Pacific Biodefense Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Technology
    • 8.1.1. Microwave Heating
    • 8.1.2. UV Light
    • 8.1.3. Gamma Radiation
    • 8.1.4. Cold Plasma
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By System
    • 8.2.1. Digital Biosurveillance Networks
    • 8.2.2. Early Warning Systems
    • 8.2.3. Biohazard Detection Systems
    • 8.2.4. AI-Assisted Surveillance System
    • 8.2.5. Biosensors
    • 8.2.6. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Military Forces
    • 8.3.2. Homeland Security
    • 8.3.3. Hospitals & Clinics
    • 8.3.4. Pharmaceutical & Biotech Companies
    • 8.3.5. Virological Research Institutes
  • 8.4. Market Analysis, Insights and Forecast - By Country
    • 8.4.1. China
      • 8.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.1.1.1. Military Forces
        • 8.4.1.1.2. Homeland Security
        • 8.4.1.1.3. Hospitals & Clinics
        • 8.4.1.1.4. Pharmaceutical & Biotech Companies
        • 8.4.1.1.5. Virological Research Institutes
    • 8.4.2. India
      • 8.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.2.1.1. Military Forces
        • 8.4.2.1.2. Homeland Security
        • 8.4.2.1.3. Hospitals & Clinics
        • 8.4.2.1.4. Pharmaceutical & Biotech Companies
        • 8.4.2.1.5. Virological Research Institutes
    • 8.4.3. Japan
      • 8.4.3.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.3.1.1. Military Forces
        • 8.4.3.1.2. Homeland Security
        • 8.4.3.1.3. Hospitals & Clinics
        • 8.4.3.1.4. Pharmaceutical & Biotech Companies
        • 8.4.3.1.5. Virological Research Institutes
    • 8.4.4. South Korea
      • 8.4.4.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.4.1.1. Military Forces
        • 8.4.4.1.2. Homeland Security
        • 8.4.4.1.3. Hospitals & Clinics
        • 8.4.4.1.4. Pharmaceutical & Biotech Companies
        • 8.4.4.1.5. Virological Research Institutes
    • 8.4.5. Rest of Asia Pacific
      • 8.4.5.1. Market Analysis, Insights and Forecast - By End User
        • 8.4.5.1.1. Military Forces
        • 8.4.5.1.2. Homeland Security
        • 8.4.5.1.3. Hospitals & Clinics
        • 8.4.5.1.4. Pharmaceutical & Biotech Companies
        • 8.4.5.1.5. Virological Research Institutes

9. Middle East & Africa Biodefense Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Technology
    • 9.1.1. Microwave Heating
    • 9.1.2. UV Light
    • 9.1.3. Gamma Radiation
    • 9.1.4. Cold Plasma
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By System
    • 9.2.1. Digital Biosurveillance Networks
    • 9.2.2. Early Warning Systems
    • 9.2.3. Biohazard Detection Systems
    • 9.2.4. AI-Assisted Surveillance System
    • 9.2.5. Biosensors
    • 9.2.6. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Military Forces
    • 9.3.2. Homeland Security
    • 9.3.3. Hospitals & Clinics
    • 9.3.4. Pharmaceutical & Biotech Companies
    • 9.3.5. Virological Research Institutes
  • 9.4. Market Analysis, Insights and Forecast - By Country
    • 9.4.1. Iran
      • 9.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.1.1.1. Military Forces
        • 9.4.1.1.2. Homeland Security
        • 9.4.1.1.3. Hospitals & Clinics
        • 9.4.1.1.4. Pharmaceutical & Biotech Companies
        • 9.4.1.1.5. Virological Research Institutes
    • 9.4.2. Israel
      • 9.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.2.1.1. Military Forces
        • 9.4.2.1.2. Homeland Security
        • 9.4.2.1.3. Hospitals & Clinics
        • 9.4.2.1.4. Pharmaceutical & Biotech Companies
        • 9.4.2.1.5. Virological Research Institutes
    • 9.4.3. Saudi Arabia
      • 9.4.3.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.3.1.1. Military Forces
        • 9.4.3.1.2. Homeland Security
        • 9.4.3.1.3. Hospitals & Clinics
        • 9.4.3.1.4. Pharmaceutical & Biotech Companies
        • 9.4.3.1.5. Virological Research Institutes
    • 9.4.4. Turkey
      • 9.4.4.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.4.1.1. Military Forces
        • 9.4.4.1.2. Homeland Security
        • 9.4.4.1.3. Hospitals & Clinics
        • 9.4.4.1.4. Pharmaceutical & Biotech Companies
        • 9.4.4.1.5. Virological Research Institutes
    • 9.4.5. Rest of Middle East & Africa
      • 9.4.5.1. Market Analysis, Insights and Forecast - By End User
        • 9.4.5.1.1. Military Forces
        • 9.4.5.1.2. Homeland Security
        • 9.4.5.1.3. Hospitals & Clinics
        • 9.4.5.1.4. Pharmaceutical & Biotech Companies
        • 9.4.5.1.5. Virological Research Institutes

10. Latin America Biodefense Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Technology
    • 10.1.1. Microwave Heating
    • 10.1.2. UV Light
    • 10.1.3. Gamma Radiation
    • 10.1.4. Cold Plasma
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By System
    • 10.2.1. Digital Biosurveillance Networks
    • 10.2.2. Early Warning Systems
    • 10.2.3. Biohazard Detection Systems
    • 10.2.4. AI-Assisted Surveillance System
    • 10.2.5. Biosensors
    • 10.2.6. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Military Forces
    • 10.3.2. Homeland Security
    • 10.3.3. Hospitals & Clinics
    • 10.3.4. Pharmaceutical & Biotech Companies
    • 10.3.5. Virological Research Institutes
  • 10.4. Market Analysis, Insights and Forecast - By Country
    • 10.4.1. Brazil
      • 10.4.1.1. Market Analysis, Insights and Forecast - By End User
        • 10.4.1.1.1. Military Forces
        • 10.4.1.1.2. Homeland Security
        • 10.4.1.1.3. Hospitals & Clinics
        • 10.4.1.1.4. Pharmaceutical & Biotech Companies
        • 10.4.1.1.5. Virological Research Institutes
    • 10.4.2. Argentina
      • 10.4.2.1. Market Analysis, Insights and Forecast - By End User
        • 10.4.2.1.1. Military Forces
        • 10.4.2.1.2. Homeland Security
        • 10.4.2.1.3. Hospitals & Clinics
        • 10.4.2.1.4. Pharmaceutical & Biotech Companies
        • 10.4.2.1.5. Virological Research Institutes
    • 10.4.3. Mexico
      • 10.4.3.1. Market Analysis, Insights and Forecast - By End User
        • 10.4.3.1.1. Military Forces
        • 10.4.3.1.2. Homeland Security
        • 10.4.3.1.3. Hospitals & Clinics
        • 10.4.3.1.4. Pharmaceutical & Biotech Companies
        • 10.4.3.1.5. Virological Research Institutes
    • 10.4.4. Rest of Latin America
      • 10.4.4.1. Market Analysis, Insights and Forecast - By End User
        • 10.4.4.1.1. Military Forces
        • 10.4.4.1.2. Homeland Security
        • 10.4.4.1.3. Hospitals & Clinics
        • 10.4.4.1.4. Pharmaceutical & Biotech Companies
        • 10.4.4.1.5. Virological Research Institutes

11. Competitive Analysis

  • 11.1. Global Market Rank Analysis (2024)
  • 11.2. Competitive Dashboard

12. Company Profiles

  • 12.1. AirBoss Defense Group, Inc. (U.S.)
    • 12.1.1. Overview
    • 12.1.2. Products & services
    • 12.1.3. SWOT Analysis
    • 12.1.4. Recent Developments
    • 12.1.5. Strategies
    • 12.1.6. Financials (Based on Availability)
  • 12.2. Bioquell, An Ecolab Solution (U.S.)
    • 12.2.1. Overview
    • 12.2.2. Products & services
    • 12.2.3. SWOT Analysis
    • 12.2.4. Recent Developments
    • 12.2.5. Strategies
    • 12.2.6. Financials (Based on Availability)
  • 12.3. Bio-Rad Laboratories, Inc. (U.S.)
    • 12.3.1. Overview
    • 12.3.2. Products & services
    • 12.3.3. SWOT Analysis
    • 12.3.4. Recent Developments
    • 12.3.5. Strategies
    • 12.3.6. Financials (Based on Availability)
  • 12.4. BlueDot Inc. (Canada)
    • 12.4.1. Overview
    • 12.4.2. Products & services
    • 12.4.3. SWOT Analysis
    • 12.4.4. Recent Developments
    • 12.4.5. Strategies
    • 12.4.6. Financials (Based on Availability)
  • 12.5. E4life Srl (Australia)
    • 12.5.1. Overview
    • 12.5.2. Products & services
    • 12.5.3. SWOT Analysis
    • 12.5.4. Recent Developments
    • 12.5.5. Strategies
    • 12.5.6. Financials (Based on Availability)
  • 12.6. Emergent BioSolutions Inc. (U.S.)
    • 12.6.1. Overview
    • 12.6.2. Products & services
    • 12.6.3. SWOT Analysis
    • 12.6.4. Recent Developments
    • 12.6.5. Strategies
    • 12.6.6. Financials (Based on Availability)
  • 12.7. SIGA Technologies, Inc. (U.S.)
    • 12.7.1. Overview
    • 12.7.2. Products & services
    • 12.7.3. SWOT Analysis
    • 12.7.4. Recent Developments
    • 12.7.5. Strategies
    • 12.7.6. Financials (Based on Availability)
  • 12.8. Dynavax Technologies (U.S.)
    • 12.8.1. Overview
    • 12.8.2. Products & services
    • 12.8.3. SWOT Analysis
    • 12.8.4. Recent Developments
    • 12.8.5. Strategies
    • 12.8.6. Financials (Based on Availability)
  • 12.9. Alnylam Pharmaceuticals, Inc. (U.S.)
    • 12.9.1. Overview
    • 12.9.2. Products & services
    • 12.9.3. SWOT Analysis
    • 12.9.4. Recent Developments
    • 12.9.5. Strategies
    • 12.9.6. Financials (Based on Availability)
  • 12.10. Ichor Medical Systems Inc. (U.S.)
    • 12.10.1. Overview
    • 12.10.2. Products & services
    • 12.10.3. SWOT Analysis
    • 12.10.4. Recent Developments
    • 12.10.5. Strategies
    • 12.10.6. Financials (Based on Availability)
  • 12.11. Bavarian Nordic A/S (Denmark)
    • 12.11.1. Overview
    • 12.11.2. Products & services
    • 12.11.3. SWOT Analysis
    • 12.11.4. Recent Developments
    • 12.11.5. Strategies
    • 12.11.6. Financials (Based on Availability)
  • 12.12. SKAN AG (Switzerland)
    • 12.12.1. Overview
    • 12.12.2. Products & services
    • 12.12.3. SWOT Analysis
    • 12.12.4. Recent Developments
    • 12.12.5. Strategies
    • 12.12.6. Financials (Based on Availability)
  • 12.13. Smiths Detection Group Ltd (U.K.)
    • 12.13.1. Overview
    • 12.13.2. Products & services
    • 12.13.3. SWOT Analysis
    • 12.13.4. Recent Developments
    • 12.13.5. Strategies
    • 12.13.6. Financials (Based on Availability)
  • 12.14. Parsons Corporation (U.S.)
    • 12.14.1. Overview
    • 12.14.2. Products & services
    • 12.14.3. SWOT Analysis
    • 12.14.4. Recent Developments
    • 12.14.5. Strategies
    • 12.14.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
  • Table 2: Global Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
  • Table 3: Global Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 4: Global Biodefense Market (USD Bn) Forecast, By Region, 2019-2032
  • Table 5: North America Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
  • Table 6: North America Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
  • Table 7: North America Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 8: North America Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
  • Table 9: U.S. Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 10: Canada Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 11: Europe Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
  • Table 12: Europe Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
  • Table 13: Europe Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 14: Europe Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
  • Table 15: U.K. Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 16: Germany Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 17: France Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 18: Russia Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 19: Rest of Europe Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 20: Asia Pacific Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
  • Table 21: Asia Pacific Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
  • Table 22: Asia Pacific Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 23: Asia Pacific Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
  • Table 24: China Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 25: India Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 26: Japan Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 27: South Korea Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 28: Rest of Asia Pacific Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 29: Middle East & Africa Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
  • Table 30: Middle East & Africa Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
  • Table 31: Middle East & Africa Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 32: Middle East & Africa Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
  • Table 33: Iran Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 34: Israel Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 35: Saudi Arabia Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 36: Turkey Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 37: Rest of Middle East & Africa Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 38: Latin America Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
  • Table 39: Latin America Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
  • Table 40: Latin America Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 41: Latin America Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
  • Table 42: Brazil Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 43: Argentina Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 44: Mexico Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
  • Table 45: Rest of Latin America Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032

List of Figures

  • Figure 1: Global Biodefense Market Revenue Breakdown (USD Billion, %) By Region, 2025 & 2032
  • Figure 2: Global Biodefense Market (%) Breakdown By Technology, 2024 & 2032
  • Figure 3: Global Biodefense Market (USD Bn) Breakdown By Microwave Heating, 2019-2032
  • Figure 4: Global Biodefense Market (USD Bn) Breakdown By UV Light, 2019-2032
  • Figure 5: Global Biodefense Market (USD Bn) Breakdown By Gamma Radiation, 2019-2032
  • Figure 6: Global Biodefense Market (USD Bn) Breakdown By Cold Plasma, 2019-2032
  • Figure 7: Global Biodefense Market (USD Bn) Breakdown By Others, 2019-2032
  • Figure 8: Global Biodefense Market (%) Breakdown By System, 2024 & 2032
  • Figure 9: Global Biodefense Market (USD Bn) Breakdown By Digital Biosurveillance Networks, 2019-2032
  • Figure 10: Global Biodefense Market (USD Bn) Breakdown By Early Warning Systems, 2019-2032
  • Figure 11: Global Biodefense Market (USD Bn) Breakdown By Biohazard Detection Systems, 2019-2032
  • Figure 12: Global Biodefense Market (USD Bn) Breakdown By AI-Assisted Surveillance System, 2019-2032
  • Figure 13: Global Biodefense Market (USD Bn) Breakdown By Biosensors, 2019-2032
  • Figure 14: Global Biodefense Market (USD Bn) Breakdown By Others, 2019-2032
  • Figure 15: Global Biodefense Market (%) Breakdown By End User, 2024 & 2032
  • Figure 16: Global Biodefense Market (USD Bn) Breakdown By Military Forces, 2019-2032
  • Figure 17: Global Biodefense Market (USD Bn) Breakdown By Homeland Security, 2019-2032
  • Figure 18: Global Biodefense Market (USD Bn) Breakdown By Hospitals & Clinics, 2019-2032
  • Figure 19: Global Biodefense Market (USD Bn) Breakdown By Pharmaceutical & Biotech Companies, 2019-2032
  • Figure 20: Global Biodefense Market (USD Bn) Breakdown By Virological Research Institutes, 2019-2032
  • Figure 21: Global Biodefense Market Share (%) By Region, 2024 & 2032
  • Figure 22: North America Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
  • Figure 23: North America Biodefense Market Value Share (%) By Technology, 2024
  • Figure 24: North America Biodefense Market Value (USD Bn) By System, 2024 & 2032
  • Figure 25: North America Biodefense Market Value Share (%) By System, 2024
  • Figure 26: North America Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 27: North America Biodefense Market Value Share (%) By End User, 2024
  • Figure 28: North America Biodefense Market Value (USD Bn) By Country, 2024 & 2032
  • Figure 29: North America Biodefense Value Share (%) By Country, 2024
  • Figure 30: U.S. Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 31: U.S. Biodefense Market Value Share (%) By End User, 2024
  • Figure 32: Canada Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 33: Canada Biodefense Market Value Share (%) By End User, 2024
  • Figure 34: Europe Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
  • Figure 35: Europe Biodefense Market Value Share (%) By Technology, 2024
  • Figure 36: Europe Biodefense Market Value (USD Bn) By System, 2024 & 2032
  • Figure 37: Europe Biodefense Market Value Share (%) By System, 2024
  • Figure 38: Europe Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 39: Europe Biodefense Market Value Share (%) By End User, 2024
  • Figure 40: Europe Biodefense Market Value (USD Bn) By Country, 2024 & 2032
  • Figure 41: Europe Biodefense Value Share (%) By Country, 2024
  • Figure 42: U.K. Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 43: U.K. Biodefense Market Value Share (%) By End User, 2024
  • Figure 44: Germany Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 45: Germany Biodefense Market Value Share (%) By End User, 2024
  • Figure 46: France Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 47: France Biodefense Market Value Share (%) By End User, 2024
  • Figure 48: Russia Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 49: Russia Biodefense Market Value Share (%) By End User, 2024
  • Figure 50: Rest of Europe Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 51: Rest of Europe Biodefense Market Value Share (%) By End User, 2024
  • Figure 52: Asia Pacific Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
  • Figure 53: Asia Pacific Biodefense Market Value Share (%) By Technology, 2024
  • Figure 54: Asia Pacific Biodefense Market Value (USD Bn) By System, 2024 & 2032
  • Figure 55: Asia Pacific Biodefense Market Value Share (%) By System, 2024
  • Figure 56: Asia Pacific Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 57: Asia Pacific Biodefense Market Value Share (%) By End User, 2024
  • Figure 58: Asia Pacific Biodefense Market Value (USD Bn) By Country, 2024 & 2032
  • Figure 59: Asia Pacific Biodefense Value Share (%) By Country, 2024
  • Figure 60: China Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 61: China Biodefense Market Value Share (%) By End User, 2024
  • Figure 62: India Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 63: India Biodefense Market Value Share (%) By End User, 2024
  • Figure 64: Japan Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 65: Japan Biodefense Market Value Share (%) By End User, 2024
  • Figure 66: South Korea Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 67: South Korea Biodefense Market Value Share (%) By End User, 2024
  • Figure 68: Rest of Asia Pacific Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 69: Rest of Asia Pacific Biodefense Market Value Share (%) By End User, 2024
  • Figure 70: Middle East & Africa Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
  • Figure 71: Middle East & Africa Biodefense Market Value Share (%) By Technology, 2024
  • Figure 72: Middle East & Africa Biodefense Market Value (USD Bn) By System, 2024 & 2032
  • Figure 73: Middle East & Africa Biodefense Market Value Share (%) By System, 2024
  • Figure 74: Middle East & Africa Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 75: Middle East & Africa Biodefense Market Value Share (%) By End User, 2024
  • Figure 76: Middle East & Africa Biodefense Market Value (USD Bn) By Country, 2024 & 2032
  • Figure 77: Middle East & Africa Biodefense Value Share (%) By Country, 2024
  • Figure 78: Iran Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 79: Iran Biodefense Market Value Share (%) By End User, 2024
  • Figure 80: Israel Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 81: Israel Biodefense Market Value Share (%) By End User, 2024
  • Figure 82: Saudi Arabia Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 83: Saudi Arabia Biodefense Market Value Share (%) By End User, 2024
  • Figure 84: Turkey Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 85: Turkey Biodefense Market Value Share (%) By End User, 2024
  • Figure 86: Rest of Middle East & Africa Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 87: Rest of Middle East & Africa Biodefense Market Value Share (%) By End User, 2024
  • Figure 88: Latin America Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
  • Figure 89: Latin America Biodefense Market Value Share (%) By Technology, 2024
  • Figure 90: Latin America Biodefense Market Value (USD Bn) By System, 2024 & 2032
  • Figure 91: Latin America Biodefense Market Value Share (%) By System, 2024
  • Figure 92: Latin America Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 93: Latin America Biodefense Market Value Share (%) By End User, 2024
  • Figure 94: Latin America Biodefense Market Value (USD Bn) By Country, 2024 & 2032
  • Figure 95: Latin America Biodefense Value Share (%) By Country, 2024
  • Figure 96: Brazil Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 97: Brazil Biodefense Market Value Share (%) By End User, 2024
  • Figure 98: Argentina Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 99: Argentina Biodefense Market Value Share (%) By End User, 2024
  • Figure 100: Mexico Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 101: Mexico Biodefense Market Value Share (%) By End User, 2024
  • Figure 102: Rest of Latin America Biodefense Market Value (USD Bn) By End User, 2024 & 2032
  • Figure 103: Rest of Latin America Biodefense Market Value Share (%) By End User, 2024
  • Figure 104: Global Biodefense Market Rank Analysis, By Key Players, 2024